NIPH Clinical Trials Search

UMIN ID: C000000010

Registered date:01/08/2005

Cyclosporine C0 monitoring for frequently relapsing nephrotic syndrome in children

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedFrequently relapsing nephrotic syndrome in children
Date of first enrollment2000/01/01
Target sample size60
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Cyclosporine C0 monitoring


Primary OutcomeRelapse-free rate
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum1years-old
Age maximum18years-old
GenderMale and Female
Include criteria1.Primary nephrotic syndrome (proteinuria with a urinary protein-creatinine ratio >1.8 and hypoalbuminemia with serum albumin level <2.5 g/dL). 2.Frequently relapses or prednisolone dependence, based on the International study of kidney disease in children. 3.Biopsy diagnoses of MCNS, MPGN or FSGS, where a renal biopsy has been performed before eligibility. 4.Aged twelve months to 18 years. 5.Written informed consent from the patients' parents or legal guardians.
Exclude criteria1.Other renal or systemic forms of nephrotic syndrome defined on renal biopsy, clinical features or serology (Henoch-Sch&ouml;nlein nephritis, systemic lupus erythematosus). 2.History of steroid-resistance. 3.Medical history of allergy or hypersensitivity reactions to cyclosporine. 4.Poorly controlled hypertension. 5.Chronic renal dysfunction. 6.Active infectious disease. 7.Severe liver disfunction. 8.History of cyclosporine administration. 9.Pregnancy. 10.Judged inappropriate for this study by the physicians.

Related Information


public contact
Address Japan
Affiliation Japanese Study Group of Renal Disease in Children Department of Nephrology,Tokyo Metropolitan Children&#039;s Hospital
scientific contact
Name Masahiro Ikeda
Address 1-3-1Umezono Kiyose City,Tokyo Japan
Affiliation Tokyo Metropolitan Children&#039;s Hospital Department of Nephrology